2704 J . Org. Chem., Vol. 65, No. 9, 2000
Iglesias et al.
2.07 (d, J ) 0.8 Hz, 3H), 4.1-4.2 (m, 2H), 5.66 (tq, J ) 6.0,
1.3 Hz, 1H), 6.65 (s, 1H), 6.88 (s, 1H), 7.4-7.6 (m, 5H); 13C
NMR (100 MHz, CDCl3) δ -5.2 (2×), 16.8, 18.2, 19.1, 21.3,
21.9, 25.9 (3×), 29.0 (2×), 33.1, 34.2, 39.4, 60.2, 121.1, 124.2
(2×), 128.5, 128.8 (2×), 129.8, 130.7, 131.0, 132.9, 137.7, 141.6,
143.6 (2×); HRMS calcd for C32H46D2O2SSi 526.3270, found
526.3262.
alcohol 33 (0.24 g, 0.70 mmol) with Et3N (0.29 mL, 2.10 mmol)
and chlorodiphenylphosphine (0.25 mL, 2.10 mmol) provided
1
0.28 g (77%) of allene 34. H NMR (400 MHz, CDCl3) δ 0.85
(s, 3H), 0.93 (s, 3H), 1.4-1.6 (m, 4H), 1.43 (s, 3H), 1.49 (s, 3H),
1.90 (t, J ) 6.2 Hz, 2H), 1.93 (s, 3H), 2.67 (br s, 2H), 3.8-3.9
(m, 2×, 4H), 5.04 (br t, 1H), 5.56 (d, J ) 6.4 Hz, 1H), 5.85 (d,
4J H-P ) 10.4 Hz, 1H), 6.12 (d, J ) 6.4 Hz, 1H), 7.4-7.5 (m,
6H), 7.6-7.7 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 14.9, 18.1
(3J C-P ) 5.0 Hz), 20.4, 20.7, 28.7, 29.1, 29.3, 33.8, 35.8, 40.6,
65.7 (2×), 101.3, 104.5 (3J C-P ) 13.2 Hz), 107.2 (1J C-P ) 99.7
Hz), 126.6 (3J C-P ) 7.0 Hz), 129.1 (3J C-P ) 13.0 Hz), 129.3
(3J C-P ) 3.9 Hz), 132.5 (2J C-P ) 9.9 Hz), 132.6 (4J C-P ) 5.8
Hz), 132.7, 133.0, 133.9, 135.1, 136.7, 214.2 (2J C-P ) 5.9 Hz);
IR (NaCl) υ 1900 (w, CdCdC) cm-1; UV (MeOH) λmax 224, 246
nm; HRMS calcd for C34H41O3P 528.2793, found 528.2782.
(6E)-8-[(ter t-Bu tyld im eth ylsilyl)oxy]-6-m eth ylocta -1,6-
d ien -4-yn -3-ol (29). According to the general procedure
described above, the reaction of alkyne 24 (0.41 g, 1.96 mmol),
acrolein (0.10 g, 1.78 mmol), and n-BuLi (0.72 mL, 2.84 M in
hexane, 2.05 mmol) afforded, after purification by flash chro-
matography on silica gel (88:10:2 hexane/EtOAc/Et3N), 0.45 g
1
(87%) of alkenynol 29. H NMR (400 MHz, CDCl3) δ 0.07 (s,
6H), 0.89 (s, 9H), 1.79 (d, J ) 0.8 Hz, 3H), 4.25 (d, J ) 6.0 Hz,
2H), 5.00 (br s, 1H), 5.23 (d, J ) 10.1 Hz, 1H), 5.47 (d, J )
16.9 Hz, 1H), 5.95 (t, J ) 6.0 Hz, 1H), 6.00 (m, 1H); 13C NMR
(100 MHz, CDCl3) δ -4.8 (2×), 18.0, 18.8, 26.3 (3×), 60.4, 64.0,
85.5, 89.0, 116.9, 118.3, 137.4, 138.1; IR (NaCl) υ 3600-3100
(br, O-H) cm-1; UV (MeOH) λmax 230 nm; HRMS calcd for
(2E)-2-Meth yl-4-(2,6,6-tr im eth ylcycloh ex-2-en -1-yl)bu t-
2-en a l (37). To a three-necked Morton flask equipped with a
mechanical stirrer and a solid addition funnel were added
R-ionone 36 (10.0 g, 52 mmol), methyl chloroacetate (12.25 mL,
0.14 mol), and MeOH (20 mL). The solution was cooled to -10
°C, and MeONa (9.6 g, 0.18 mol) was added in small portions
for 2 h. After stirring at 0 °C for 3 h, a solution of 15% NaOH
in MeOH (50 mL) was added and the resulting mixture was
stirred at 5 °C for 2 h, after which time it was allowed to reach
25 °C. Water was added (60 mL) and the final solution was
stirred for 30 min at 25 °C. The two layers were separated,
and the aqueous layer was extracted with Et2O (3×). The
combined organic layers were washed with water (3×), dried
(Na2SO4), filtered and evaporated. Purification by flash chro-
matography on silica gel (95:5 hexane/EtOAc) afforded 6.20 g
(58%) of aldehyde 37 as a clear yellow oil. 1H NMR (400 MHz,
CDCl3) δ 0.79 (s, 3H), 0.82 (s, 3H), 1.0-1.2 (m, 1H), 1.2-1.4
(m, 1H), 1.59 (d, J ) 1.8 Hz, 3H), 1.67 (d, J ) 1.1 Hz, 3H),
1.71 (br t, J ) 5.1 Hz, 1H), 1.8-2.0 (m, 2H), 2.38 (td, J ) 6.2,
0.9 Hz, 2H), 5.34 (br s, 1H), 6.50 (td, J ) 7.1, 1.3 Hz, 1H),
9.30 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 9.2, 22.8, 23.2, 27.4
(2×), 30.0, 31.5, 32.4, 49.2, 121.9, 134.5, 138.0, 155.8, 195.0;
HRMS calcd for C14H22O 206.1671, found 206.1667.
(2E,7E)-9-[(ter t-Bu tyld im eth ylsilyl)oxy]-3,7-d im eth yl-
1-(2,6,6-tr im eth ylcycloh ex-2-en -1-yl)n on a -2,7-d ien -5-yn -
4-ol (38). According to the general procedure described above,
the reaction of aldehyde 37 (0.5 g, 2.43 mmol), alkyne 24 (0.57
g, 2.70 mol), and n-BuLi (1.27 mL, 2.55 M in hexane, 3.24
mmol) in THF (8 mL), afforded, after flash chromatography
on silica gel (90:10 hexane/EtOAc), 0.56 g (56%) of propargylic
alcohol 38 as a yellow oil. (See Supporting Information for
characterization data).
ter t-Bu t yld im et h ylsilyl (7E,9Z,11Z,13E)-12-(P h en yl-
su lfin yl)-4,6-r etr or etin yl Eth er (39). Following the general
procedure described above, treatment of propargylic alcohol
38 (0.22 g, 0.53 mmol) with phenylsulfenyl chloride (0.23 g,
1.59 mmol) and Et3N (0.20 mL, 1.59 mmol) in THF (18 mL)
afforded, after flash chromatography on silica gel (93:6:1
hexane/EtOAc/Et3N), 0.11 g (40%) of sulfoxide 39. An analyti-
cal sample for characterization was purified by HPLC (85:15
hexane/EtOAc). (See Supporting Information for characteriza-
tion data).
ter t-Bu tyld im eth ylsilyl (7E,9Z,11E,13E)-4,6-r etr oReti-
n yl Eth er (40). Following the general procedure described
above, the reaction of sulfoxide 39 (0.03 g, 0.06 mmol) in THF
(4 mL) with MeOH (13 µL, 0.31 mmol), MeLi (40 µL, 1.6 M in
Et2O, 0.06 mmol), and tert-BuLi (0.36 mL, 1.7 M in pentane,
0.62 mmol) afforded, after purification by chromatography
(C18, 100% CH3CN), 0.02 g (73%) of silyl ether 40. (See
Supporting Information for characterization data).
(7E,9Z,11E,13E)-4,6-r etr oRetin oic Acid (42). Following
the general procedure described above, compound 40 (0.01 g,
0.03 mmol) was deprotected by treatment with TBAF (33 µL,
1.0 M in THF, 0.03 mmol) to afford alcohol 41. The residue
was immediately oxidized, according to the general procedure,
with MnO2 (14 mg, 0.16 mmol) and Ag2O (38 mg, 0.16 mmol)
to provide, after purification by chromatography (SiO2, 98:2
CH2Cl2/MeOH), 4 mg (53%) of carboxylic acid 42. (See Sup-
porting Information for characterization data).
C
15H26O2Si 266.1702, found 266.1696.
ter t-Bu t yld im et h ylsilyl (2E,6E)-6-Met h yl-1-(p h en yl-
su lfin yl)octa -2,6-d ien -4-yn -8-yl Eth er ((E)-31). In accor-
dance to the general procedure described above, the reaction
of Et3N (0.16 mL, 1.11 mmol), alkenynol 29 (0.10 g, 0.37 mmol),
and phenylsulfenyl chloride (0.16 g, 1.11 mmol) in THF (10
mL) afforded, after purification by flash chromatography (83:
15:2 hexane/EtOAc/Et3N), 0.12 g (89%) of sulfoxide (E)-31 as
a yellow oil. 1H NMR (400 MHz, CDCl3) δ 0.07 (s, 6H), 0.90 (s,
9H), 1.78 (d, J ) 1.2 Hz, 3H), 3.55 (ddd, J ) 12.8, 7.8, 0.8 Hz,
1H), 3.63 (ddd, J ) 12.8, 7.8, 0.8 Hz, 1H), 4.25 (d, J ) 6.2 Hz,
2H), 5.65 (d, J ) 15.6 Hz, 1H), 5.85 (dt, J ) 15.6, 7.8 Hz, 1H),
1
5.92 (td, J ) 6.3, 1.2 Hz, 1H), 7.5-7.6 (m, 5H); H NMR (400
MHz, C6D6) δ 0.00 (s, 6H), 0.93 (s, 9H), 1.62 (s, 3H), 2.85 (ddd,
J ) 12.8, 7.8, 1.1 Hz, 1H), 2.98 (ddd, J ) 12.8, 7.8, 1.1 Hz,
1H), 4.07 (d, J ) 6.2 Hz, 2H), 5.47 (d, J ) 15.7 Hz, 1H), 5.76
(dt, J ) 15.7, 7.8 Hz, 1H), 6.14 (td, J ) 6.2, 1.4 Hz, 1H), 6.9-
7.0 (m, 3H), 7.3-7.5 (dd, J ) 7.8, 2.3 Hz, 2H); 13C NMR (100
MHz, CDCl3) δ -4.7 (2×), 17.9, 26.3 (3×), 38.0, 60.4, 60.9, 84.9,
94.2, 118.9, 124.7 (2×), 129.0, 129.5, 129.6 (2×), 131.8, 138.2,
142.9; UV (MeOH) λmax 278 nm; HRMS [M - t-Bu] calcd for
C17H21O2SSi 317.1032, found 317.1026. 1H NMR for (Z)-31 (400
MHz, C6D6) δ 0.01 (s, 6H), 0.94 (s, 9H), 1.60 (s, 3H), 3.47 (dd,
J ) 12.7, 7.8 Hz, 1H), 3.57 (dd, J ) 12.7, 7.8 Hz, 1H), 4.08 (d,
J ) 6.2 Hz, 2H), 5.5-5.6 (m, 2H), 6.00 (t, J ) 6.2 Hz, 1H),
7.0-7.2 (m, 3H), 7.44 (d, J ) 7.8 Hz, 2H).
ter t-Bu tyld im eth ylsilyl (8E,13E)-12-(Dip h en ylp h osp h i-
n oyl)-11,7-r etr or etin yl Eth er (32). Gen er a l P r oced u r e for
th e P r ep a r a tion of Allen ylp h osp h in e Oxid es. To a cooled
(-78 °C) solution of propargylic alcohol 10 (0.10 g, 0.24 mmol)
in THF (1.3 mL) was added, dropwise, Et3N (0.10 mL, 0.73
mmol), followed by chlorodiphenylphosphine (0.02 mL, 0.3
mmol). After stirring at -78 °C for 3 h and at 25 °C for an
additional 3 h, the solvent was evaporated. The residue was
purified by flash chromatography on silica gel (82:15:3 hexane/
EtOAc/Et3N) to provide, in order of elution, 0.07 g (70%) of
allene 32 as a colorless oil, and 0.03 g of unreacted starting
1
material. H NMR (400 MHz, CDCl3) δ -0.11 (s, 6H), 0.76 (s,
9H), 0.83 (s, 3H), 0.91 (s, 3H), 1.4-1.6 (m, 4H), 1.42 (s, 3H),
1.51 (s, 3H), 1.78 (s, 3H), 1.88 (t, J ) 6.1 Hz, 2H), 2.65 (br s,
4
2H), 4.21 (d, J ) 6.0 Hz, 2H), 5.00 (m, 1H), 5.80 (d, J H-P
)
10.5 Hz, 1H), 6.14 (t, J ) 6.0 Hz, 1H), 7.4-7.5 (m, 6H), 7.6-
7.7 (m, 4H); 13C NMR (100 MHz, CDCl3) δ -4.8 (2×), 14.3,
16.9, 17.0 (3J C-P ) 5.2 Hz), 18.6, 19.9, 20.1, 26.2 (3×), 28.1,
28.6, 28.8, 33.3, 35.3, 40.1, 60.9, 103.7 (3J C-P ) 13.5 Hz), 107.1
(1J C-P ) 101.3 Hz), 126.3 (3J C-P ) 7.1 Hz), 128.2 (3J C-P ) 7.0
Hz), 128.4 (3J C-P ) 9.0 Hz), 128.5, 128.6, 128.7 (3J C-P ) 9.0
Hz), 131.9, 132.0 (2J C-P ) 9.0 Hz, 2×), 132.0 (2J C-P ) 10.4 Hz,
2×), 132.7 (3J C-P ) 4.9 Hz), 132.8 (4J C-P ) 4.7 Hz), 133.8, 136.2,
213.0 (2J C-P ) 5.9 Hz); IR (NaCl) υ 1910 (w, CdCdC) cm-1
;
UV (MeOH) λmax 224, 246 nm; HRMS calcd for C38H53O2PSi
600.3552, found 600.3551.
(8E,13E)-14-[1,3]-Dioxola n -2-yl}-12-(d ip h en ylp h osp h i-
n oyl)-11,7-r etr or etin yl Eth er (34). In accordance to the
general procedure described above, treatment of propargylic